Page 30 - Read Online
P. 30

attacks, orthostatic hypotension, impaired heart-rate   treatment with low doses of AChE-Is and/or steroids.
           variability  (HRV) [18,19] ). These significant cardiac   The patients were admitted to the hospital for 24-48 h
           manifestations were reported in patients with severe   for the purpose of the research. Twenty healthy subjects
           stages of MG and in the presence of thymoma. It has   matched for age, sex and socioeconomic status were
           been suggested that some MG patients may develop   included in this study for statistical comparisons. Control
           autonomic dysfunction and other nervous system     subjects were recruited from the general population. This
           manifestations. [18-26]  It has also been suggested that the   study was accepted by the regional Ethical Committee.
           heart and skeletal muscle molecules are targets for the   All patients and control subjects were briefed about the
           autoimmune process of MG. [27-30]                  detailed information of this study and hence consented
                                                              to attend this study.
           This  study  aimed  to  assess  cardiac  functions  in
           patients with MG using Ambulatory 24-h ECG Holter   Excluded were subjects (patients and controls): (1)
           Monitoring. HRV measures are sensitive indices     with respiratory involvement or in crisis (i.e., severe
           of cardiac autonomic function  (sympathetic and    stage of the disease); (2) with major systemic illness
           parasympathetic).                                  such as organic heart disease, diabetes, hypertension
                                                              or any other disease that might affect the autonomic
           METHODS                                            nervous system; (3) on medications known to affect
                                                              heart-rate/rhythm such as beta-blockers, vasopressors,
           Subjects                                           digitalis, theophylline, thyroid hormones, tricyclic
           This study included 20 (males = 6, females = 14)   antidepressant, antiarrythmic drugs, atropine and its
           patients with MG without known cardiac diseases. Their   derivatives, etc.; (4) with history of febrile illness in
           age range is was 16-50 years and duration of illness   the past 1-week; and (5) with lack of sound sleep the
           ranged from 1 to 4 years. Clinical grading of the patients   night prior to monitoring.
           was done based on the medical-scientific advisory board
                                                  [4]
           of the MG Foundation of America classification.  Patients   Measurements
           grading was based on their histories and diagnosis shown   All  participants  underwent  conventional
           in their medical records. Patients reported histories of   echocardiography and Ambulatory ECG
           weakness of ocular muscles (ptosis) (class I), with mild   Holter-Monitoring. Holter monitoring is the continuous
           and predominant weakness of limb muscles (class IIa) or   24-h monitoring of ECG activity of a patient’s heart
           oropharyngeal muscles (class IIb), or with moderate and   while engaged in daily activities. Ambulatory ECG
           predominant weakness of limbs (class IIIa). Thymectomy   was carried out using the 5-electrode Holter which
           was done to the seven patients with thymoma. Table 1   is a 3-channel portable battery operated digital ECG
           shows the demographic and clinical characteristics   recorder (Cardiolight FMC.A, Medset, Medizintecknik,
           of the studied group. Patients were recruited from the   Hamburg, Germany). The standard Holter report
           Out-patient Clinic of the Department of Neurology,   includes data for heart-rate, ventricular ectopies (VEs),
           Assiut University Hospital, Assiut, Egypt during their   supraventricular ectopies (SVEs), HRV, ST, QT, QTc (QT
           follow-up visits in which they were free of clinical   corrected for heart-rate), atrial fibrillation  (A-Fib),
           manifestations (i.e., after resolution of active stage of the   T-wave alternans and sleep apnea.
           disease for at least 3 months) and were on maintenance
                                                              Heart-rate variability is defined as the oscillation in
           Table 1: Demographic, clinical and laboratory      the interval between consecutive heart beats as well
           characteristics of the studied groups              as the oscillations between consecutive instantaneous
           Demographic and     Patients   Control subjects   P  heart-rate. [31]  The general concept of HRV is that the
           clinical characteristics  (n = 20)  (n = 20)       more the HRV, the healthier the heart, because it more
           Male/female           6/14        10/10      ‑     readily responds to its various stimuli. Small changes
           Age; years           16‑50        20‑50      ‑
                              28.45 ± 8.89  30.22 ± 5.76  0.380  in R-R (NN) variability indicate cardiac risk. However,
           Duration of illness;   1‑4         ‑         ‑     small or large changes in variability cannot be noticed
           years              3.52 ± 1.15     ‑         ‑     at ECG strips. Two correlated methods of calculating
           Clinical grade
            I                     0           ‑         ‑     R-R changes have been accepted by the cardiology
            IIa/IIb              2/10         ‑         ‑     community , which are the time-domain and frequency.
            IIIa/IIIb            8/0          ‑         ‑     In this study, we analyzed the HRV in the time-domain.
                                                                                                            [32]
            IVa/IVb               0           ‑         ‑
            V                     0                           The most acceptable measurements in time-domain
           Thymic pathology (%)                               are: (1) SDNN (ms): standard deviation of all qualified
            Normal              5 (25)        ‑         ‑     beats  (NN intervals);  (2) SDANN  (ms): standard
            Hyperplasia         8 (40)        ‑         ‑
            Thymoma             7 (35)                        deviation of the averages of NN intervals in all 5-min
           Data are expressed as range, mean ± SD; number (%). SD: Standard deviation  segments of the entire recording; (3) RMS-SD (ms):


            22                                             Neuroimmunol Neuroinflammation | Volume 2 | Issue 1 | January 15, 2015
   25   26   27   28   29   30   31   32   33   34   35